Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP

Implementing Pharmacogenomic Testing: Overcoming Financial Barriers

Implementing Pharmacogenomic Testing: Overcoming Financial Barriers

Understanding Pharmacogenomic Testing and Its Financial Implications

Pharmacogenomic testing holds the promise of revolutionizing healthcare by tailoring drug therapies to an individual's genetic makeup. This personalized approach aims to optimize drug efficacy and minimize adverse reactions. However, the widespread adoption of pharmacogenomic testing faces significant hurdles, particularly financial ones. The research article "Are patients willing to incur out of pocket costs for pharmacogenomic testing?" explores these challenges and offers insights for practitioners seeking to integrate pharmacogenomics into their practice.

Key Findings from the Research

The study surveyed participants from the Mayo Clinic's RIGHT Protocol, which aims to incorporate pharmacogenomics into clinical practice. It found that while many patients recognize the value of pharmacogenomic testing, a significant portion is unwilling to pay out of pocket for these tests unless covered by insurance. Financial strain was a major factor influencing this unwillingness, with 42% of participants not willing to incur any out-of-pocket costs. Of those willing to pay, 87% would not spend more than $250.

Implications for Practitioners

For practitioners, these findings highlight the need to advocate for broader insurance coverage of pharmacogenomic testing. Here are some steps practitioners can take:

Encouraging Further Research

While the study provides valuable insights, it also underscores the need for further research. Practitioners should consider engaging in or supporting studies that explore:

Conclusion

Pharmacogenomic testing represents a significant advancement in personalized medicine, but its potential is hindered by financial barriers. Practitioners play a crucial role in overcoming these challenges by educating patients, advocating for insurance coverage, and supporting further research. By doing so, they can help ensure that the benefits of pharmacogenomics are accessible to all patients, regardless of their financial situation.

To read the original research paper, please follow this link: Are patients willing to incur out of pocket costs for pharmacogenomic testing?


Citation: Bielinski, S. J., St. Sauver, J. L., Olson, J. E., Wieland, M. L., Vitek, C. R., Bell, E. J., McGree, M. E., Jacobson, D. J., McCormick, J. B., Takahashi, P. Y., Black, J. L., Caraballo, P. J., Sharp, R. R., Beebe, T. J., Weinshilboum, R. M., Wang, L., & Roger, V. L. (2017). Are patients willing to incur out of pocket costs for pharmacogenomic testing? The Pharmacogenomics Journal. https://doi.org/10.1038/tpj.2016.72
Marnee Brick, President, TinyEYE Therapy Services

Author's Note: Marnee Brick, TinyEYE President, and her team collaborate to create our blogs. They share their insights and expertise in the field of Speech-Language Pathology, Online Therapy Services and Academic Research.

Connect with Marnee on LinkedIn to stay updated on the latest in Speech-Language Pathology and Online Therapy Services.

Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP

Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP